Joo Ern Ang

1PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 19, 2022
A Phase I Trial of CT900, a Novel α-Folate Receptor-Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer.

Susana Banerjee, Vasiliki Michalarea, Joo Ern Ang

Pageof 1

Frequent Collaborators

1 joint publications

Susana Banerjee

1 joint publications

Vasiliki Michalarea

1 joint publications

Alvaro Ingles Garces

1 joint publications

Andrea Biondo